As ordered reported by the House Committee on Ways and Means on February 26, 2015
H.R. 1021 would make numerous changes to the Medicare and Medicaid programs aimed at improving the accuracy of their payments and reducing fraud and waste.
Over the 2015-2025 period, CBO estimates that H.R. 1021 would reduce direct spending by $19 million and increase revenues by $10 million, for a net reduction in deficits of $29 million. Pay-as-you-go procedures apply because enacting the legislation would affect direct spending and revenues. H.R. 1021 would also have discretionary costs, subject to the availability of appropriated funds; CBO has not completed an estimate of those costs.
H.R. 1021 contains no intergovernmental or private-sector mandates as defined in the Unfunded Mandates Reform Act.